- Global Pharma News & Resources

Vitruvia Medical AG: auhtorised capital increase

Vitruvia Medical AG / Key word(s): Capital Increase
Vitruvia Medical AG: auhtorised capital increase

27-March-2023 / 11:34 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Ad Hoc Announcement

Anglikon, 27 March 2023: Vitruvia Medical AG has carried out an authorised capital increase as of today. Receivables in the amount of CHF 1'680'817.50 were offset, for which 672'327 registered shares at CHF 1.00 each were issued. The issue price was CHF 2.50 per registered share. The share capital of Vitruvia Medical AG now amounts to CHF 2,511,578.00.

Vitruvia Medical AG

Markus A. Bertschin

Chairman of the Board of Directors


27-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Vitruvia Medical AG
Kesselackerstr. 18
5611 Anglikon
Phone: +41 44 915 33 78
ISIN: CH0461931419
Listed: Regulated Unofficial Market in Munich
EQS News ID: 1593069

End of Announcement EQS News Service

Editor Details

Last Updated: 27-Mar-2023